7-9 November 2023, digital and in-person event
The world of life sciences is in a period of relentless disruption. Advances in technology are transforming research and development. Innovative treatments such as mRNA vaccines and cell therapies are reshaping healthcare as we know it. Meanwhile, companies face the challenge of bringing products to market in an unsettled regulatory environment.
The FT Global Pharma and Biotech Summit brings together industry leaders and experts to share insights and perspectives on what’s new in areas such as drug discovery, clinical trials, market access and patient engagement.
Chief Commercial Officer
Wednesday, November 8, 11:45 AM - 12:05 PM GMT
Fireside Chat: Partnering for progress - Best practices to drive efficiency and effectiveness in drug development
CROs continue to become more integrated as they develop and implement new technologies and operational models that make development cycles more efficient and effective. This session will explore the current environment for partnerships and examine best practices to leverage combined knowledge and accelerate progress, including developing bespoke partnership operating models, ensuring cultural alignment between organisations, and establishing effective change management strategies and communication plans.
Vice President, Patient Recruitment & Retention
Wednesday, November 8, 12:05 PM - 12:45 PM GMT
Panel: How is Patient Engagement Evolving Clinically and Commercially?
From clinical trials to consultations, technology is transforming patient engagement across health systems. As new products are developed and market conditions evolve, pharma companies are changing how they connect with patients on every level.
Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry
Véronique Walsh, General Manager and Vice President, UK and Ireland, Gilead Sciences
Hanno Ronte, Partner, Deloitte